Search Results - David Lorente
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
Circulating Tumor Cells: A Multifunctional Biomarker by Timothy A. Yap, David Lorente, Aurelius Omlin, David Olmos, Johann S. de Bono
Published 2014Revisão -
2
-
3
Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline... by David Lorente, Joaquı́n Mateo, Arnoud J. Templeton, Zafeiris Zafeiriou, Diletta Bianchini, Roberta Ferraldeschi, Amit Bahl, Liji Shen, Zhen Su, Oliver Sartor, Johann S. de Bono
Published 2014Artigo -
4
Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Pro... by Jonathan Welti, Daniel Nava Rodrigues, Adam Sharp, Shihua Sun, David Lorente, Ruth Riisnaes, Ines Figueiredo, Zafeiris Zafeiriou, Pasquale Rescigno, Johann S. de Bono, Stephen R. Plymate
Published 2016Artigo -
5
Visceral Disease in Castration-resistant Prostate Cancer by Carmel Pezaro, Aurelius Omlin, David Lorente, Daniel Nava Rodrigues, Roberta Ferraldeschi, Diletta Bianchini, Deborah Mukherji, Ruth Riisnaes, Amelia Altavilla, Mateus Crespo, Nina Tunariu, Johann S. de Bono, Gerhardt Attard
Published 2013Carta -
6
ATIM-16. PHASE 1 STUDY RESULTS OF M7824 (MSB0011359C), A BIFUNCTIONAL FUSION PROTEIN TARGETING TGF- AND PD-L1, AMONG PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM) by Khasraw, Mustafa, Weller, Michael, Estelles, David Lorente, Kolibaba, Kathryn, Lee, Chee, Gedye, Craig, De La Fuente, Macarena, Vicente, David, Reardon, David, Ojalvo, Laureen, Helwig, Christoph, Gourmelon, Carole, Groves, Morris
Published 2018Text -
7
Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone by David Lorente, Aurelius Omlin, Roberta Ferraldeschi, Carmel Pezaro, Raquel Pérez-López, Joaquı́n Mateo, Amelia Altavilla, Zafeiris Zafeirou, Nina Tunariu, Chris Parker, David P. Dearnaley, Silke Gillessen, Johann S. de Bono, Gerhardt Attard
Published 2014Artigo -
8
Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts by David Lorente, David Olmos, Joaquı́n Mateo, David Dolling, Diletta Bianchini, George Seed, Penelope Flohr, Mateus Crespo, I. Figueiredo, Susana Miranda, Howard I. Scher, Leon W.M.M. Terstappen, Johann S. de Bono
Published 2018Artigo -
9
Impact of Obesity on Quality of Life, Psychological Distress, and Coping on Patients with Colon Cancer by Gomez, David, Jimenez‐Fonseca, Paula, Fernández, Aránzazu Manzano, Castellanos, Patricia Cruz, Arbizu, Maria Valero, Cabañes, Ruth Martínez, Estellés, David Lorente, Ferreira, Estrella, del Rio, Jorge, García, Teresa García, Carmona‐Bayonas, Alberto, Calderon, Caterina
Published 2021Text -
10
Tumor clone dynamics in lethal prostate cancer by Suzanne Carreira, Alessandro Romanel, Jane Goodall, Emily Grist, Roberta Ferraldeschi, Susana Miranda, Davide Prandi, David Lorente, Jean‐Sébastien Frénel, Carmel Pezaro, Aurelius Omlin, Daniel Nava Rodrigues, Penelope Flohr, Nina Tunariu, Johann S. de Bono, Francesca Demichelis, Gerhardt Attard
Published 2014Artigo -
11
First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate can... by Diletta Bianchini, Aurelius Omlin, Carmel Pezaro, David Lorente, Roberta Ferraldeschi, Deborah Mukherji, Mateus Crespo, I. Figueiredo, Susana Miranda, Ruth Riisnaes, Andrea Zivi, Aby Buchbinder, Dana E. Rathkopf, Gerhardt Attard, Howard I. Scher, Johann S. de Bono, Daniel C. Danila
Published 2013Artigo -
12
Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents by Mateus Crespo, Guus van Dalum, Roberta Ferraldeschi, Zafeiris Zafeiriou, Spyridon Sideris, David Lorente, Diletta Bianchini, Daniel Nava Rodrigues, Ruth Riisnaes, Susana Miranda, I. Figueiredo, Penelope Flohr, Karolina Nowakowska, Johann S. de Bono, Leon W.M.M. Terstappen, Gerhardt Attard
Published 2015Artigo -
13
Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair gene... by David Olmos, David Lorente, Daniel Alameda, Carlo Cattrini, Nuria Romero-Laorden, Rosa M. Lozano, Pedro P. López‐Casas, Ana Jambrina, C. Capone, A.M. Vanden Broecke, Marco Trevisan, Suzy Van Sanden, A Jürgens, Bernardo Herrera‐Imbroda, Elena Castro
Published 2024Artigo -
14
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers by Jorge E. Cortés, Kenji Tamura, Daniel J. DeAngelo, Johann S. de Bono, David Lorente, Mark D. Minden, Geoffrey L. Uy, Hagop M. Kantarjian, Lisa S. Chen, Varsha Gandhi, Robert Godin, Karen Keating, Kristen McEachern, Karthick Vishwanathan, J. Elizabeth Pease, Emma Dean
Published 2018Artigo -
15
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer by Pasquale Rescigno, David Lorente, Diletta Bianchini, Roberta Ferraldeschi, Michael Paul Kolinsky, Spyridon Sideris, Zafeiris Zafeiriou, Semini Sumanasuriya, Alan D. Smith, Niven Mehra, Anuradha Jayaram, Raquel Pérez-López, Joaquı́n Mateo, Chris Parker, David P. Dearnaley, Nina Tunariu, Alison Reid, Gerhardt Attard, Johann S. de Bono
Published 2016Artigo -
16
Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer by David Lorente, David Olmos, Joaquı́n Mateo, Diletta Bianchini, George Seed, Martin Fleisher, Daniel C. Danila, Penny Flohr, Mateus Crespo, Ines Figueiredo, Susana Miranda, Kurt Baeten, Arturo Molina, Thian Kheoh, Robert McCormack, Leon W.M.M. Terstappen, Howard I. Scher, Johann S. de Bono
Published 2016Artigo -
17
Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study by Raquel Pérez-López, Joaquı́n Mateo, Helen Mossop, Matthew Blackledge, David J. Collins, Mihaela Rata, Veronica A. Morgan, Alison Macdonald, Shahneen Sandhu, David Lorente, Pasquale Rescigno, Zafeiris Zafeiriou, Diletta Bianchini, Núria Porta, Emma Hall, Martin O. Leach, Johann S. de Bono, Dow‐Mu Koh, Nina Tunariu
Published 2016Artigo -
18
Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma by Bert H. O’Neil, John M. Wallmark, David Lorente, Elena Élez, Judith Raimbourg, Carlos Gomez‐Roca, Samuel Ejadi, Sarina A. Piha‐Paul, Mark N. Stein, Albiruni R. Abdul Razak, Katia Dotti, Armando Santoro, Roger B. Cohen, M. Gould, Sanatan Saraf, Karen Stein, Sae‐Won Han
Published 2017Artigo -
19
PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate by Roberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, Susana Miranda, Ines Figueiredo, Pasquale Rescigno, Praful Ravi, Carmel Pezaro, Aurelius Omlin, David Lorente, Zafeiris Zafeiriou, Joaquı́n Mateo, Amelia Altavilla, Spyridon Sideris, Diletta Bianchini, Emily Grist, Khin Thway, Raquel Pérez-López, Nina Tunariu, Chris Parker, David P. Dearnaley, Alison Reid, Gerhardt Attard, Johann S. de Bono
Published 2014Artigo -
20
Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration by Jean‐Sébastien Frenel, Suzanne Carreira, Jane Goodall, Desam Roda, Raquel Pérez-López, Nina Tunariu, Ruth Riisnaes, Susana Miranda, Ines Figueiredo, Daniel Nava Rodrigues, Alan D. Smith, Christophe Leux, Isaac García-Murillas, Roberta Ferraldeschi, David Lorente, Joaquı́n Mateo, Michael Ong, Timothy A. Yap, Udai Banerji, Delila Gasi Tandefelt, Nicholas C. Turner, Gerhardt Attard, Johann S. de Bono
Published 2015Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Cancer
Oncology
Prostate cancer
Biology
Cancer research
Biochemistry
Androgen receptor
Prostate
Biomarker
Confidence interval
Gene
Genetics
Abiraterone acetate
Androgen deprivation therapy
Chemistry
Circulating tumor cell
Enzalutamide
Gastroenterology
Hazard ratio
Hormone
Metastasis
Pathology
Proportional hazards model
Urology
Abiraterone
Adverse effect
Apoptosis
Bioinformatics